What is HekaFlo.
HekaFlo high-flow nasal cannula oxygen therapy (HFNC) device is an innovative respiratory support system for the treatment of spontaneously breathing hypoxic patients with 100% humidified and heated oxygen at a flow rate of up to 60 LPM. This treatment is highly effective for patients with Post-COVID complications having difficulty in breathing or shortness of breath.
HFNC is an effective and safe initial respiratory support treatment in children less than two years with mild to moderate respiratory failure due to pneumonia.
Why choose HekaFlo
HekaFlo HM-P-500 generates gas flow rates up to 60 L/min.
Electronic air-O2 blender achieves escalation of FiO2 from 21% to 100%.
Humidifier saturates the gas mixture at temperature of 31 to 37 C.
Large Touch Screen
4.3-inch TFT touch screen, which allows quick operation by touch and ease of use.
WiFi & Bluetooth
Wi-Fi and Low energy Bluetooth module for wireless connectivity.
World’s first IoT enabled HFNC device in the market.
Web based dashboard and native iOS and Android apps for remote patient monitoring.
Integrated Pulse Oximeter
Integrated pulse oximeter to report the SpO2 and pulse rate values.
Adult mode and Pediatric mode with pre-defined range for flow rate.
AI Driven Reports
Artificial Intelligence (AI) driven reports & charts to evaluate patient conditions.
HekaFlo has built-in flow meter and ROX index Calculator.
Safe & Comfortable
Ultra-quiet blower, soft & comfortable nasal cannula and built-in system alerts.
Key benefits of HekaFlo oxygenation therapy
The flow rate for traditional oxygen therapy is up to 15 liters per minutes and HFNO based high flow oxygen therapy is up to 60 L/min. According to American Journal of Respiratory and Critical Care Medicine, this newer mode of delivering supplemental oxygen at high flows (40–60 L/min) permits high FiO2; the gas is heated and humidified to avoid mucosal injury and patient discomfort, overcoming the key problems of past use of high flow rates.